Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective

The newly emerged human coronavirus, SARS-CoV-2, had begun to spread last year and sparked worldwide. In this study, molecular docking is utilized to test some previously approved drugs against the SARS-CoV-2 nonstructural protein 15 (Nsp15). We screened 23 drugs, from which three (saquinavir, valru...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Future Virol
Päätekijät: Mahmud, Shafi, Elfiky, Abdo A, Amin, Al, Mohanto, Sumon Chandro, Rahman, Ekhtiar, Acharjee, Uzzal Kumar, Saleh, Abu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2021
Aiheet:
Short Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285111/
https://ncbi.nlm.nih.gov/pubmed/34290822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fvl-2020-0233
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia